These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7904244

  • 1. Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors.
    Meller E, Bohmaker K, Goldstein M, Basham DA.
    Eur J Pharmacol; 1993 Nov 02; 249(1):R5-6. PubMed ID: 7904244
    [Abstract] [Full Text] [Related]

  • 2. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
    Meller E, Helmer-Matyjek E, Bohmaker K, Adler CH, Friedhoff AJ, Goldstein M.
    Eur J Pharmacol; 1986 Apr 16; 123(2):311-4. PubMed ID: 3709668
    [Abstract] [Full Text] [Related]

  • 3. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun 16; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 4. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jun 16; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 5. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 6. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS, Bergstrom DA, Gonzalez AM, Huang KX, Sibley DR, Walters JR.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):209-14. PubMed ID: 7493610
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E, Tonello C, Imhof R, Scherschlicht R, da Prada M, Carruba MO.
    J Pharmacol Exp Ther; 1993 Jul 24; 266(1):97-105. PubMed ID: 8101225
    [Abstract] [Full Text] [Related]

  • 8. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 24; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 9. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A, Fadda F, Melis MR, Marcou M, Porceddu ML, Gessa GL.
    Eur J Pharmacol; 1982 Nov 05; 85(1):23-7. PubMed ID: 6818043
    [Abstract] [Full Text] [Related]

  • 10. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
    Levant B, DeSouza EB.
    Synapse; 1993 May 05; 14(1):90-5. PubMed ID: 8099762
    [Abstract] [Full Text] [Related]

  • 11. The effects of pertussis toxin on dopamine D2 and serotonin 5-HT1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve.
    Bohmaker K, Bordi F, Meller E.
    Neuropharmacology; 1992 May 05; 31(5):451-9. PubMed ID: 1356248
    [Abstract] [Full Text] [Related]

  • 12. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ, Bunney EB, Zigun JR, Skirboll LR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun 05; 312(2):161-5. PubMed ID: 6772975
    [Abstract] [Full Text] [Related]

  • 13. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb 05; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 14. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 05; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 15. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D, Hjorth S, Carlsson A.
    Eur J Pharmacol; 1984 Oct 30; 106(1):185-9. PubMed ID: 6099268
    [Abstract] [Full Text] [Related]

  • 16. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
    Levant B, Grigoriadis DE, De Souza EB.
    Eur J Pharmacol; 1995 May 24; 278(3):243-7. PubMed ID: 7589161
    [Abstract] [Full Text] [Related]

  • 17. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A.
    Behav Pharmacol; 2009 Jul 24; 20(4):303-11. PubMed ID: 19584712
    [Abstract] [Full Text] [Related]

  • 18. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA, Davis MD, Akunne HC, Cooke LW, Whetzel SZ, MacKenzie RG, Shih YH, van Leeuwen DH, DeMattos SB, Georgic LM.
    J Pharmacol Exp Ther; 1995 Aug 24; 274(2):898-911. PubMed ID: 7636753
    [Abstract] [Full Text] [Related]

  • 19. Isomeric selectivity at dopamine D3 receptors.
    Baldessarini RJ, Kula NS, McGrath CR, Bakthavachalam V, Kebabian JW, Neumeyer JL.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):269-70. PubMed ID: 8223909
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.